ArticleSurgical endoscopy2026
Initial clinical experience of a novel single-port axillary to midline (SAM) approach robotic thyroidectomy using a single-port robotic surgical system.
Article in Surgical endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRobotic thyroidectomy has evolved through remote-access approaches to improve cosmetic outcomes while maintaining surgical safety. Although the bilateral axillo-breast approach (BABA) provides a stable bilateral operative view, it requires multiple incisions, including periareolar incisions, which may raise cosmetic concerns in some female patients. With the introduction of the da Vinci SP robotic system, we developed the single-port axillary to midline (SAM) approach, a modification of BABA that accesses the thyroid gland through the midline between the strap muscles via a single axillary incision while preserving a stable bilateral operative view. This study evaluated the feasibility, safety, and early clinical outcomes of robotic thyroidectomy using the SAM approach.
methodsThis retrospective study included 63 patients who underwent SAM approach robotic thyroidectomy between February and September 2025 at Gibbeum Hospital. Demographics, operative time by surgical step, pathology, and postoperative outcomes were analyzed.
resultsOf the 63 patients, 53 (84.1%) were female and 10 (15.9%) were male. Lobectomy was performed in 56 patients (88.9%) and total thyroidectomy was performed in 5 patients (7.9%). The mean total operative time was 147.4 ± 37.5 min, significantly longer in total thyroidectomy than lobectomy (241.0 ± 24.4 vs. 138.4 ± 22.8 min, p < 0.01). Flap creation, docking, and closure times did not differ significantly between the two groups. The mean tumor size was 1.0 ± 0.7 cm; 96.0% of malignancies were papillary thyroid carcinoma. The mean number of metastatic central lymph nodes was 1.3 ± 2.0, with 6.7 ± 4.1 harvested nodes. Transient vocal cord palsy occurred in one patient (1/63, 1.6%), and transient hypoparathyroidism occurred in one patient (1/5, 20.0%), with complete recovery. No major complications were observed. Axillary scars were well concealed within the natural skin crease.
conclusionsThe SAM approach appears to be a feasible and cosmetically favorable single-port robotic thyroidectomy technique. Further studies are needed to validate long-term oncologic safety.
Indexed as
Identifiers
42426401What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.